An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene

After three decades of intensive research efforts, an effective vaccine against HIV-1 remains to be developed. Several broadly neutralizing antibodies to HIV-1, such as 10E8, recognize the membrane proximal external region (MPER) of the HIV-1 gp41 protein. Thus, the MPER is considered to be a very i...

Full description

Bibliographic Details
Main Authors: Zhiwu Sun, Yun Zhu, Qian Wang, Ling Ye, Yanyan Dai, Shan Su, Fei Yu, Tianlei Ying, Chinglai Yang, Shibo Jiang, Lu Lu
Format: Article
Language:English
Published: Taylor & Francis Group 2016-01-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1038/emi.2016.86
_version_ 1797679125062746112
author Zhiwu Sun
Yun Zhu
Qian Wang
Ling Ye
Yanyan Dai
Shan Su
Fei Yu
Tianlei Ying
Chinglai Yang
Shibo Jiang
Lu Lu
author_facet Zhiwu Sun
Yun Zhu
Qian Wang
Ling Ye
Yanyan Dai
Shan Su
Fei Yu
Tianlei Ying
Chinglai Yang
Shibo Jiang
Lu Lu
author_sort Zhiwu Sun
collection DOAJ
description After three decades of intensive research efforts, an effective vaccine against HIV-1 remains to be developed. Several broadly neutralizing antibodies to HIV-1, such as 10E8, recognize the membrane proximal external region (MPER) of the HIV-1 gp41 protein. Thus, the MPER is considered to be a very important target for vaccine design. However, the MPER segment has very weak immunogenicity and tends to insert its epitope residues into the cell membrane, thereby avoiding antibody binding. To address this complication in vaccine development, we herein designed a peptide, designated 10E8-4P, containing four copies of the 10E8 epitope as an immunogen. As predicted by structural simulation, 10E8-4P exhibits a well-arranged tandem helical conformation, with the key residues in the 10E8 epitope oriented at different angles, thus suggesting that some of these key residues may be exposed outside of the lipid membrane. Compared with a peptide containing a single 10E8 epitope (10E8-1P), 10E8-4P not only exhibited better antigenicity but also elicited neutralizing antibody response against HIV-1 pseudoviruses, whereas 10E8-1P could not induce detectable neutralizing antibody response. Importantly, antibodies elicited by 10E8-4P also possessed a strong ability to activate an antibody-dependent cell-mediated cytotoxicity (ADCC) reporter gene, thus suggesting that they may have ADCC activity. Therefore, this strategy shows promise for further optimization and application in future HIV-1 vaccine design.Emerging Microbes and Infections (2016) 5, e65; doi:10.1038/emi.2016.86; published online 22 June 2016
first_indexed 2024-03-11T23:09:51Z
format Article
id doaj.art-e3f3bdde87814ac18094b728e5c7b602
institution Directory Open Access Journal
issn 2222-1751
language English
last_indexed 2024-03-11T23:09:51Z
publishDate 2016-01-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj.art-e3f3bdde87814ac18094b728e5c7b6022023-09-21T12:27:55ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512016-01-015111210.1038/emi.2016.86An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter geneZhiwu Sun0Yun Zhu1Qian Wang2Ling Ye3Yanyan Dai4Shan Su5Fei Yu6Tianlei Ying7Chinglai Yang8Shibo Jiang9Lu Lu10Key Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Fudan University, Shanghai 200032, ChinaNational Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, ChinaKey Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Fudan University, Shanghai 200032, ChinaDepartment of Microbiology and Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USAKey Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Fudan University, Shanghai 200032, ChinaKey Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Fudan University, Shanghai 200032, ChinaKey Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Fudan University, Shanghai 200032, ChinaKey Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Fudan University, Shanghai 200032, ChinaDepartment of Microbiology and Immunology and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USAKey Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Fudan University, Shanghai 200032, ChinaKey Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Fudan University, Shanghai 200032, ChinaAfter three decades of intensive research efforts, an effective vaccine against HIV-1 remains to be developed. Several broadly neutralizing antibodies to HIV-1, such as 10E8, recognize the membrane proximal external region (MPER) of the HIV-1 gp41 protein. Thus, the MPER is considered to be a very important target for vaccine design. However, the MPER segment has very weak immunogenicity and tends to insert its epitope residues into the cell membrane, thereby avoiding antibody binding. To address this complication in vaccine development, we herein designed a peptide, designated 10E8-4P, containing four copies of the 10E8 epitope as an immunogen. As predicted by structural simulation, 10E8-4P exhibits a well-arranged tandem helical conformation, with the key residues in the 10E8 epitope oriented at different angles, thus suggesting that some of these key residues may be exposed outside of the lipid membrane. Compared with a peptide containing a single 10E8 epitope (10E8-1P), 10E8-4P not only exhibited better antigenicity but also elicited neutralizing antibody response against HIV-1 pseudoviruses, whereas 10E8-1P could not induce detectable neutralizing antibody response. Importantly, antibodies elicited by 10E8-4P also possessed a strong ability to activate an antibody-dependent cell-mediated cytotoxicity (ADCC) reporter gene, thus suggesting that they may have ADCC activity. Therefore, this strategy shows promise for further optimization and application in future HIV-1 vaccine design.Emerging Microbes and Infections (2016) 5, e65; doi:10.1038/emi.2016.86; published online 22 June 2016https://www.tandfonline.com/doi/10.1038/emi.2016.86ADCCHIV-1neutralizing antibodies10E8 epitopes
spellingShingle Zhiwu Sun
Yun Zhu
Qian Wang
Ling Ye
Yanyan Dai
Shan Su
Fei Yu
Tianlei Ying
Chinglai Yang
Shibo Jiang
Lu Lu
An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene
Emerging Microbes and Infections
ADCC
HIV-1
neutralizing antibodies
10E8 epitopes
title An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene
title_full An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene
title_fullStr An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene
title_full_unstemmed An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene
title_short An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene
title_sort immunogen containing four tandem 10e8 epitope repeats with exposed key residues induces antibodies that neutralize hiv 1 and activates an adcc reporter gene
topic ADCC
HIV-1
neutralizing antibodies
10E8 epitopes
url https://www.tandfonline.com/doi/10.1038/emi.2016.86
work_keys_str_mv AT zhiwusun animmunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT yunzhu animmunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT qianwang animmunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT lingye animmunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT yanyandai animmunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT shansu animmunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT feiyu animmunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT tianleiying animmunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT chinglaiyang animmunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT shibojiang animmunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT lulu animmunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT zhiwusun immunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT yunzhu immunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT qianwang immunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT lingye immunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT yanyandai immunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT shansu immunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT feiyu immunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT tianleiying immunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT chinglaiyang immunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT shibojiang immunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene
AT lulu immunogencontainingfourtandem10e8epitoperepeatswithexposedkeyresiduesinducesantibodiesthatneutralizehiv1andactivatesanadccreportergene